title: Can somatostatin be administered in association with morphine in advanced cancer patients with pain?
authors.forename: C
authors.initials: C
authors.lastname: Ripamonti
authors.forename: F
authors.initials: F
authors.lastname: De Conno
authors.forename: R
authors.initials: R
authors.lastname: Boffi
authors.forename: L
authors.initials: L
authors.lastname: Ascani
authors.forename: M
authors.initials: M
authors.lastname: Bianchi
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004347:Drug Interactions; D005260:Female; D006727:Hormone Antagonists / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009369:Neoplasms / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy*; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects; D013004:Somatostatin / Q000009:adverse effects*
chemical_list: D000701:Analgesics, Opioid; D006727:Hormone Antagonists; D011957:Receptors, Opioid; D013004:Somatostatin; D009020:Morphine